Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study
-
Published:2024-04-02
Issue:1
Volume:19
Page:
-
ISSN:1940-0640
-
Container-title:Addiction Science & Clinical Practice
-
language:en
-
Short-container-title:Addict Sci Clin Pract
Author:
Montoya Iván D., Watson Colleen, Aldridge Arnie, Ryan Danielle, Murphy Sean M., Amuchi Brenda, McCollister Kathryn E., Schackman Bruce R., Bush Joshua L., Speer Drew, Harlow Kristin, Orme Stephen, Zarkin Gary A., Castry Mathieu, Seiber Eric E., Barocas Joshua A., Linas Benjamin P., Starbird Laura E.ORCID
Abstract
Abstract
Background
Communities That HEAL (CTH) is a novel, data-driven community-engaged intervention designed to reduce opioid overdose deaths by increasing community engagement, adoption of an integrated set of evidence-based practices, and delivering a communications campaign across healthcare, behavioral-health, criminal-legal, and other community-based settings. The implementation of such a complex initiative requires up-front investments of time and other expenditures (i.e., start-up costs). Despite the importance of these start-up costs in investment decisions to stakeholders, they are typically excluded from cost-effectiveness analyses. The objective of this study is to report a detailed analysis of CTH start-up costs pre-intervention implementation and to describe the relevance of these data for stakeholders to determine implementation feasibility.
Methods
This study is guided by the community perspective, reflecting the investments that a real-world community would need to incur to implement the CTH intervention. We adopted an activity-based costing approach, in which resources related to hiring, training, purchasing, and community dashboard creation were identified through macro- and micro-costing techniques from 34 communities with high rates of fatal opioid overdoses, across four states—Kentucky, Massachusetts, New York, and Ohio. Resources were identified and assigned a unit cost using administrative and semi-structured-interview data. All cost estimates were reported in 2019 dollars.
Results
State-level average and median start-up cost (representing 8–10 communities per state) were $268,657 and $175,683, respectively. Hiring and training represented 40%, equipment and infrastructure costs represented 24%, and dashboard creation represented 36% of the total average start-up cost. Comparatively, hiring and training represented 49%, purchasing costs represented 18%, and dashboard creation represented 34% of the total median start-up cost.
Conclusion
We identified three distinct CTH hiring models that affected start-up costs: hospital-academic (Massachusetts), university-academic (Kentucky and Ohio), and community-leveraged (New York). Hiring, training, and purchasing start-up costs were lowest in New York due to existing local infrastructure. Community-based implementation similar to the New York model may have lower start-up costs due to leveraging of existing infrastructure, relationships, and support from local health departments.
Funder
Substance Abuse and Mental Health Services Administration
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Aldridge AP, Barbosa C, Barocas JA, Bush JL, Chhatwal J, Harlow KJ, Hyder A, Linas BP, McCollister KE, Morgan JR, Murphy SM, Savitzky C, Schackman BR, Seiber EE, Starbird EL, Villani J, Zarkin GA. Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study. Drug Alcohol Depend. 2020;217(October):108336. https://doi.org/10.1016/j.drugalcdep.2020.108336. 2. Behrends CN, Gutkind S, Winkelstein E, Wright M, Dolatshahi J, Welch A, Paone D, Kunins HV, Schackman BR. Costs of opioid overdose education and naloxone distribution in New York City. Subst Abuse. 2022;43(1):692–8. https://doi.org/10.1080/08897077.2021.1986877. 3. Braithwaite V, Nolan S. Hospital-based addiction medicine healthcare providers: high demand, short supply. J Addict Med. 2019;13(4):251–2. https://doi.org/10.1097/ADM.0000000000000488. 4. Chatterjee A, Weitz M, Savinkina A, Macmadu A, Madushani RWMA, Potee RA, Ryan D, Murphy SM, Walley AY, Linas BP. Estimated costs and outcomes associated with use and nonuse of medications for opioid use disorder during incarceration and at release in Massachusetts. JAMA Netw Open. 2023;6(4): e237036. https://doi.org/10.1001/jamanetworkopen.2023.7036. 5. Claypool AL, DiGennaro C, Russell WA, Yildirim MF, Zhang AF, Reid Z, Stringfellow EJ, Bearnot B, Schackman BR, Humphreys K, Jalali MS. Cost-effectiveness of increasing buprenorphine treatment initiation, duration, and capacity among individuals who use opioids. JAMA Health Forum. 2023;4(5): e231080. https://doi.org/10.1001/jamahealthforum.2023.1080.
|
|